NCT05379673 The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia
| NCT ID | NCT05379673 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Ventilatory Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-10-04 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2022-10-04 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this randomized-controlled trial the investigators will examine the effect of oxygen supplementation on the recovery of breathing for 90 minutes in the immediate post-anesthesia period starting from extubation of the trachea.
Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) physical status I-III * Body mass index (BMI) less than 40 kg/m2 * Scheduled to undergo robotic-assisted radical laparoscopic nephrectomy or prostatectomy. Exclusion Criteria: * Patients with a diagnosis of chronic obstructive pulmonary disorder (COPD), severe neurological, cardiopulmonary, psychiatric, or untreated thyroid disorder * Chronic pain condition that is being treated with opioids * Patients with a hematocrit lower than 30% at the end of surgery, or those with an excessive blood loss, requiring transfusion of blood products during surgery.
Contact & Investigator
Anthony Doufas, MD, PhD
PRINCIPAL INVESTIGATOR
Professor, Department of Anesthesiology, Stanford University Medical School
Frequently Asked Questions
Who can join the NCT05379673 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Ventilatory Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05379673 currently recruiting?
Yes, NCT05379673 is actively recruiting participants. Contact the research team at agdoufas@stanford.edu for enrollment information.
Where is the NCT05379673 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT05379673 clinical trial?
NCT05379673 is sponsored by Stanford University. The principal investigator is Anthony Doufas, MD, PhD at Professor, Department of Anesthesiology, Stanford University Medical School. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.